Patents by Inventor Joan Pinas

Joan Pinas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060025450
    Abstract: The invention provides a method for the treatment of polyposis which comprises treating a subject suffering from polyposis with an H+, K+-ATPase inhibitor and, optionally, a glucocorticoid. The invention also relates to a pharmaceutical formulation for simultaneous, separate or sequential administration in the treatment of Widal's Syndrome and in the treatment of asthma.
    Type: Application
    Filed: February 14, 2005
    Publication date: February 2, 2006
    Inventors: Per Lindberg, Joan Pinas-Masso, Jordi Serra-Carreras, Jan Trofast
  • Publication number: 20050137764
    Abstract: An energy management system for controlling an electrical system comprises data collection components, such as sensors, for providing quantified variables for forming an instantaneous state vector. A time series predictor generates an estimated future vector value in response to the instantaneous state vector. An electrical system manager includes predetermined decision rules invoked in response to the estimated future vector value to adapt the electrical system to expected electrical conditions.
    Type: Application
    Filed: December 19, 2003
    Publication date: June 23, 2005
    Inventors: Ignacio Alvarez-Troncoso, Joan Pinas, Jordi Guasch
  • Publication number: 20030216439
    Abstract: The invention provides a method for the treatment of polyposis which comprises treating a subject suffering from polyposis with an H+, K+-ATPase inhibitor and, optionally, a glucocorticoid. The invention also relates to a pharmaceutical formulation for simultaneous, separate or sequential administration in the treatment of Widal's Syndrome and in the treatment of asthma.
    Type: Application
    Filed: June 11, 2003
    Publication date: November 20, 2003
    Inventors: Per Lindberg, Joan Pinas-Masso, Jordi Serra-Carreras, Jan Trofast
  • Patent number: 6599927
    Abstract: The invention provides a method for the treatment of polyposis which comprises treating a subject suffering from polyposis with an H+, K+-ATPase inhibitor and, optionally, a glucocorticoid. The invention also relates to a pharmaceutical formulation for simultaneous, separate or sequential administration in the treatment of Widal's Syndrome and in the treatment of asthma.
    Type: Grant
    Filed: April 13, 2001
    Date of Patent: July 29, 2003
    Assignee: AstraZeneca AB
    Inventors: Per Lindberg, Joan Piñas-Massó, Jordi Serra-Carreras, Jan Trofast
  • Patent number: 6380222
    Abstract: The invention provides a method for the treatment of polyposis which comprises treating a subject suffering from polyposis with an H+,K+-ATPase inhibitor and, optionally, a glucocorticoid. The invention also relates to a pharmaceutical formulation for simultaneous, separate or sequential administration in the treatment of Widal's Syndrome and in the treatment of asthma.
    Type: Grant
    Filed: April 13, 2001
    Date of Patent: April 30, 2002
    Assignee: AstraZeneca AB
    Inventors: Per Lindberg, Joan Piñas-Massó, Jordi Serra-Carreras, Jan Trofast
  • Publication number: 20010029255
    Abstract: The invention provides a method for the treatment of polyposis which comprises treating a subject suffering from polyposis with an H+, K+-ATPase inhibitor and, optionally, a glucocorticoid. The invention also relates to a pharmaceutical formulation for simultaneous, separate or sequential administration in the treatment of Widal's Syndrome and in the treatment of asthma.
    Type: Application
    Filed: April 13, 2001
    Publication date: October 11, 2001
    Inventors: Per Lindberg, Joan Pinas-Masso, Jordi Serra-Carreras, Jan Trofast
  • Publication number: 20010020014
    Abstract: The invention provides a method for the treatment of polyposis which comprises treating a subject suffering from polyposis with an H+,K+-ATPase inhibitor and, optionally, a glucocorticoid. The invention also relates to a pharmaceutical formulation for simultaneous, separate or sequential administration in the treatment of Widal's Syndrome and in the treatment of asthma.
    Type: Application
    Filed: April 13, 2001
    Publication date: September 6, 2001
    Inventors: Per Lindberg, Joan Pinas-Masso, Jordi Serra-Carreras, Jan Trofast